Completion of recruitment to a prospective, open-label clinical investigation of Arthrosamid for knee osteoarthritis Posted on 17 October 2019 | by Originmeister | Leave a Comment on Completion of recruitment to a prospective, open-label clinical investigation of Arthrosamid for knee osteoarthritis
Commencement of a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis Posted on 15 June 2019 | by Originmeister | Leave a Comment on Commencement of a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis
Acquisition of Manufacturing Facility in Copenhagen, Denmark Posted on 25 May 2018 | by Originmeister | Leave a Comment on Acquisition of Manufacturing Facility in Copenhagen, Denmark
Searchlight Pharma Announces Launch of Bulkamid® for Treatment of Female Stress Urinary Incontinence Posted on 10 May 2018 | by Originmeister | Leave a Comment on Searchlight Pharma Announces Launch of Bulkamid® for Treatment of Female Stress Urinary Incontinence
Speciality European Pharma Limited to rebrand as Contura in order to consolidate its corporate structure and drive growth Posted on 19 January 2018 | by Originmeister | Leave a Comment on Speciality European Pharma Limited to rebrand as Contura in order to consolidate its corporate structure and drive growth
Contura files Bulkamid PMA Posted on 30 July 2017 | by Originmeister | Leave a Comment on Contura files Bulkamid PMA
Speciality European Pharma sells Mitem to Substipharm Limited Posted on 27 April 2017 | by Originmeister | Leave a Comment on Speciality European Pharma sells Mitem to Substipharm Limited
Speciality European Pharma signs clinical research agreement with Central Manchester University Hospitals NHS Foundation Trust for the study of Bulkamid as a first line treatment for stress urinary incontinence Posted on 17 February 2017 | by Originmeister | Leave a Comment on Speciality European Pharma signs clinical research agreement with Central Manchester University Hospitals NHS Foundation Trust for the study of Bulkamid as a first line treatment for stress urinary incontinence
Speciality European Pharma extends distribution agreement for Regurin XL in the United Kingdom Posted on 20 December 2016 | by Originmeister | Leave a Comment on Speciality European Pharma extends distribution agreement for Regurin XL in the United Kingdom
MBO at SEP provides capital to accelerate growth and expansion Posted on 1 May 2016 | by Originmeister | Leave a Comment on MBO at SEP provides capital to accelerate growth and expansion